Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $48.66 and last traded at $48.61, with a volume of 114786 shares traded. The stock had previously closed at $46.70.
Analyst Ratings Changes
Separately, BNP Paribas lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.
Read Our Latest Stock Analysis on SDZNY
Sandoz Group Stock Up 4.1 %
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
See Also
- Five stocks we like better than Sandoz Group
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Must-Have ETFs Set to Dominate This Quarter
- What is a Death Cross in Stocks?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Investing in Travel Stocks Benefits
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
